Related references
Note: Only part of the references are listed.Significance of Conducting 2 Types of Fecal Tests in Patients With Ulcerative Colitis
Makoto Naganuma et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Ulcerative colitis
Taku Kobayashi et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Efficacy of Therapeutic Intervention for Patients With an Ulcerative Colitis Mayo Endoscopic Score of 1
Tomohiro Fukuda et al.
INFLAMMATORY BOWEL DISEASES (2019)
Evidence-based clinical practice guidelines for inflammatory bowel disease
Katsuyoshi Matsuoka et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries
Taku Kobayashi et al.
INTESTINAL RESEARCH (2018)
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
Fernando Magro et al.
JOURNAL OF CROHNS & COLITIS (2017)
Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus
L. Vuitton et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Mucosal Healing in Ulcerative Colitis - When Zero is Better
Pedro Boal Carvalho et al.
JOURNAL OF CROHNS & COLITIS (2016)
Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study
Manuel Barreiro-de Acosta et al.
JOURNAL OF CROHNS & COLITIS (2016)
Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases
Joana Torres et al.
JOURNAL OF CROHNS & COLITIS (2016)
Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission
Jae Hyun Kim et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2016)
Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials
V. Jairath et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
L. Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Clinical application of faecal calprotectin in ulcerative colitis patients
Eleonora Scaioli et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
An endoscopic Mayo score of 0 is associated with a lower risk of colectomy than a score of 1 in ulcerative colitis
Claire Manginot et al.
GUT (2015)
Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy
Takayuki Yamamoto et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2014)
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)
Simon P. L. Travis et al.
GUT (2012)
Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: A prospective, multicenter study
Gianmichele Meucci et al.
INFLAMMATORY BOWEL DISEASES (2012)
Mucosal Healing Predicts Late Outcomes After the First Course of Corticosteroids for Newly Diagnosed Ulcerative Colitis
Sandro Ardizzone et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
Jean Frederic Colombel et al.
GASTROENTEROLOGY (2011)
Treating rheumatoid arthritis to target: recommendations of an international task force
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
The pattern and outcome of acute severe colitis
Lotte C. Dinesen et al.
JOURNAL OF CROHNS & COLITIS (2010)
Mucosal healing in inflammatory bowel disease: Results from a Norwegian population-based cohort
Kathrine Frey Froslie et al.
GASTROENTEROLOGY (2007)
Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years
Ole Hoie et al.
GASTROENTEROLOGY (2007)
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Mark S. Silverberg et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis
M Rutter et al.
GASTROENTEROLOGY (2004)
Share Paper
